Immunology

Reviewing new challenges and opportunities for hepatitis B cures

Hepatitis B virus (HBV) is a significant public health problem, with over 296 million people chronically infected worldwide. Despite the availability of a safe and effective vaccine for over 40 years, HBV remains a leading ...

Diseases, Conditions, Syndromes

New tool to study hepatitis B could open the door to a cure

Hepatitis C and hepatitis B viruses both attack the liver, eventually causing deadly cirrhosis or cancer. But while antivirals can cure 95% of HCV infections, its cousin HBV has long eluded effective therapeutics. As a result, ...

Diseases, Conditions, Syndromes

CDC: All adults should be screened for hepatitis B

People with chronic hepatitis B virus (HBV) infection are at in increased risk for liver cancer, cirrhosis and are 70% to 85% more likely to die prematurely than the general population, according to the Atlanta-based Centers ...

Diseases, Conditions, Syndromes

CDC updates recommendations for hepatitis B virus screening

Recommendations have been updated for screening and testing for hepatitis B virus (HBV) infection, according to research published in the March 10 issue of the U.S. Centers for Disease Control and Prevention Morbidity and ...

Diseases, Conditions, Syndromes

New standards to quantify hepatitis B virus reservoirs in liver cells

Approximately 300 million people are chronically infected with the hepatitis B virus (HBV), which can cause liver cirrhosis or cancer. Consequently, there is an urgent need for the development of HBV curative therapies. Due ...

page 1 from 11